Meiji Yasuda Asset Management CO Ltd. Teva Pharmaceutical Industries LTD Transaction History

Meiji Yasuda Asset Management CO Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $137,977 - $204,309	-16,100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $130,731 - $211,232	16,100 New	16,100 $199,000
Q1 2020 May 14, 2020	SELL	$6.69 - $13.45 $90,315 - $181,575	-13,500 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$8.12 - $15.72 $6,495 - $12,576	-800 Reduced 5.59%	13,500 $125,000
Q4 2018 Feb 12, 2019	BUY	$14.59 - $23.84 $1,459 - $2,384	100 Added 0.7%	14,300 $221,000
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $21,060 - $25,650	1,000 Added 7.58%	14,200 $306,000
Q2 2018 Aug 13, 2018	SELL	$16.77 - $24.71 $13,416 - $19,768	-800 Reduced 5.71%	13,200 $321,000
Q1 2018 May 14, 2018	BUY	$16.68 - $22.07 $36,696 - $48,554	2,200 Added 18.64%	14,000 $239,000
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $60,642 - $103,140	-5,400 Reduced 31.4%	11,800 $224,000
Q3 2017 Nov 08, 2017	BUY	$15.41 - $32.17 $265,052 - $553,324	17,200	17,200 $303,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.